Skip to main content
MOVE
NASDAQ Technology

Corvex Registers 53.4M Shares for Resale, Creating a Potential 94% Overhang on the Current Float

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$16.79
Mkt Cap
$33.262M
52W Low
$3.439
52W High
$26.72
52W Position info
388% above low
Off High info
37% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

MOVE has more than doubled off its 52-week low of $3.439.

Summary

Corvex's S-1 registers 53.4 million shares for resale by insiders and early investors — a potential 94% overhang on the current float. The company gets no cash; selling stockholders get liquidity.


Key Events · Financing and Capital Events · MOVE

  • Massive Resale Registration

    Registration of 53,390,008 shares for resale, consisting of 28.9M shares from Series D Preferred conversions and 24.5M already issued from prior conversions. This could nearly double the public float.

  • Insider Liquidity Event

    Selling stockholders include co-CEOs Seth Demsey (20% owner) and Jay Crystal (14.7% owner), along with other early investors. The company receives no proceeds from any sales.

  • Overhang Risk

    If all 53.4M shares were sold, they would represent approximately 94% of the current 27.6M shares outstanding, creating significant potential selling pressure.

  • Recent Dilution Context

    This filing follows the July 7 shareholder approval of massive dilution, converting preferred stock into 27.6M common shares, and the July 9 13D filings revealing co-CEOs' large stakes.


Analysis · MOVE · Technology

Corvex filed an S-1 to register 53.4 million shares for resale by selling stockholders, including co-CEOs and early investors. This represents a potential 94% increase over the current 27.6 million shares outstanding. The company receives no proceeds — this is purely a liquidity event for insiders who acquired shares through the recent reverse merger and preferred stock conversions. Coming just days after the massive dilution approved at the annual meeting and the 13D filings showing co-CEOs' large stakes, this registration signals that major holders are preparing to exit, which could flood the market and pressure the stock.

How filings like this one have moved

In the 30 days to Aug 23, 2026, 43.6% of the 1008 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MOVE was trading at $16.79 on NASDAQ in the Technology sector, with a market capitalization of approximately $33.3M. The 52-week trading range was $3.44 to $26.72. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MOVE - Latest Insights

MOVE
Aug 14, 2026, 4:20 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $11.83
Real-time Price: $8.68 info
Change: -$3.15 (-27%) info
Market Cap: $242.467M info
MOVE
Aug 14, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $10.31
Real-time Price: $8.68 info
Change: -$1.63 (-16%) info
Market Cap: $242.467M info
MOVE
Aug 04, 2026, 8:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $21.13
Real-time Price: $8.68 info
Change: -$12.45 (-59%) info
Market Cap: $242.467M info
MOVE
Jul 08, 2026, 8:13 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $16.54
Real-time Price: $8.68 info
Change: -$7.86 (-48%) info
Market Cap: $242.467M info
MOVE
Jul 08, 2026, 8:13 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $16.54
Real-time Price: $8.68 info
Change: -$7.86 (-48%) info
Market Cap: $242.467M info